stockrow
Friday 6 November 2026
Export VSEE’s income statement to Excel — free account
VSee Health, Inc.
VSEE Healthcare Health Information Services
VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.
- Revenue
- −53.9%
- EPS
- +109.9%
- Free cash flow
- −257.6%
- Total debt
- +31.6%
Quarter to June 2026, against a year earlier
1.15
0.00
0.00%
Follow VSEE
Alert me
| Dec '17 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 4 |
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | (9.97) | (15.02) | (6.06) |
P/S ratio |
— | — | — | 0.00 | 1.33 | 0.52 |
Altman Z″-Score (non-manufacturers) |
— | — | — | (92.01) | (37.18) | (16.83) |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | (13.92) | (4.22) |
P/Operating CF |
— | — | — | (1,117.22) | (4.67) | (3.92) |
P/B ratio |
— | — | — | 0.00 | 0.00 | 1.38 |
Price to Tangible BV |
— | — | — | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 1.36 | 0.21 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | (192.67) | (2.45) | (0.89) |
EV/FCF |
— | — | — | (191.37) | (2.42) | (0.88) |
Quick Ratio |
— | 4.13 | 0.03 | 0.14 | 0.11 | 0.48 |
Current Ratio |
— | 6.61 | 0.03 | 0.16 | 0.16 | 0.52 |
Net Debt/EBITDA |
— | 2.69 | 0.03 | 0.07 | (0.07) | 0.67 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 2.97% | 2.65% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | (32.10) | 0.11 |
Asset Turnover |
— | 0.00 | 0.00 | 1.37 | 1.00 | 0.69 |
Operating CF/Net income |
— | 2.14 | 0.43 | 0.17 | 0.10 | 0.23 |
Capex/Depreciation |
— | — | — | (0.05) | 0.00 | (0.01) |
Interest Coverage |
— | (141.35) | (28.53) | (9.79) | (293.86) | (3.41) |
| — | 0.00% | 60.26% | 64.18% | 2,672.63% | (541.52%) | |
| — | (0.48%) | (5.16%) | (89.17%) | (554.87%) | (69.39%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (15,581.33%) | (767.86%) |
Return on Tangible Assets |
— | (27.16%) | 101.69% | 87.52% | 376.91% | 194.96% |
Average Days of Receivables |
— | — | — | 38.20 | 60.12 | 62.94 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 97.46% | 113.81% | 115.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.80 | 0.61 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 8.60% | 7.69% |
Graham Net Nets |
— | — | — | (0.04) | (1.22) | (1.14) |
Graham Number |
— | — | — | 151.89 | 31.85 | 0.00 |
Earnings Yield |
— | — | — | (3.05%) | (286.10%) | (195.10%) |
Free Cash Flow Yield |
— | — | — | (0.52%) | (42.07%) | (46.29%) |
Revenue per Share |
— | 0.00 | 0.00 | 46.13 | 81.61 | 58.05 |
Operating CF per Share |
— | (12.05) | (8.73) | (5.06) | (45.34) | (13.68) |
Capex per Share |
— | 0.00 | 0.00 | (0.03) | (0.43) | (0.12) |
Free Cash Flow per Share |
— | (12.05) | (8.73) | (5.10) | (45.77) | (13.80) |
Cash per Share |
— | 15.26 | 0.67 | 0.95 | 2.55 | 20.91 |
Shareholders Equity per Share |
— | (66.96) | (46.62) | (34.40) | (0.14) | 21.65 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (66.96) | (46.62) | (34.40) | (0.14) | 21.65 |
Free Cash Flow |
— | (0.60) | (1.39) | (0.64) | (5.84) | (3.48) |
Working Capital |
— | 1.03 | (3.19) | (4.30) | (15.99) | (7.88) |
Capital Expenditures |
— | — | — | 0.00 | (0.06) | (0.03) |
Net Current Asset Value |
— | (120.06) | (14.95) | (4.30) | (16.99) | (8.60) |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.01 | 0.00 |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
— | — | — | 25.51 | 85.36 | 7.98 |
Cash ROIC |
— | 23.31% | 19.01% | 15.23% | (648.34%) | (30.72%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 8.98 | 6.90 |
Accounts Payable Turnover |
— | — | 0.00 | 0.86 | 0.54 | 0.70 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 488.31 | 1,051.38 | 579.84 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | 1.16 | 2.12 |
Average Payables |
— | — | 1.01 | 2.24 | 5.97 | 10.44 |
Average Assets |
— | 58.97 | 62.79 | 4.22 | 10.40 | 21.20 |
Average Common Equity |
— | — | (5.38) | (5.86) | (2.16) | 2.72 |
Columns are period end dates · fundamentals updated 2 Nov 2026